Painful Intercourse (Dyspareunia) — Causes, Diagnosis & Treatment Guide — Symptoms, Causes & Treatment | MyMedicPlus

Painful intercourse (dyspareunia) is defined as recurrent or persistent genital pain associated with sexual intercourse, which causes marked personal distress. It affects women more commonly than men (up to 20% of women vs 1-5% of men), though it is underreported in both sexes due to embarrassment and the misconception that pain during sex is normal or inevitable. Dyspareunia is classified as superficial (at the vaginal entrance or penile shaft — typically from skin conditions, vulvodynia, vaginismus, or infection) or deep (occurring with deep penetration — typically from endometriosis, pelvic inflammatory disease, ovarian cysts, or bladder conditions). Pain during intercourse is never 'normal' and always warrants clinical assessment — it significantly impacts quality of life, relationships, psychological wellbeing, and sexual function. With appropriate diagnosis and treatment, most cases are successfully managed.

In women — superficial dyspareunia: vulvodynia (chronic vulvar pain without identifiable cause — provoked vestibulodynia is the most common subtype, with pain on touch at the vaginal entrance); vaginismus (involuntary pelvic floor muscle spasm preventing or causing pain with penetration); vulvovaginal atrophy/genitourinary syndrome of menopause (GSM — oestrogen deficiency causing vaginal dryness, thinning, and loss of elasticity); vulval dermatological conditions (lichen sclerosus, lichen planus, contact dermatitis); infections (candidiasis, herpes simplex, trichomoniasis, bacterial vaginosis); Bartholin's cyst or abscess; skin conditions (psoriasis, eczema); and trauma or scarring from perineal tears, episiotomy, or female genital mutilation. In women — deep dyspareunia: endometriosis (most common cause of deep dyspareunia), ovarian cysts, pelvic inflammatory disease, uterine fibroids, pelvic adhesions, pelvic organ prolapse, and interstitial cystitis/painful bladder syndrome. In men: phimosis (tight foreskin), balanitis, Peyronie's disease (painful fibrous plaques causing penile curvature during erection), prostatitis, and skin conditions of the penis. Psychological factors contribute to all forms of dyspareunia — anxiety, depression, relationship difficulties, and history of sexual trauma — and can themselves cause or perpetuate pain.

Characterising the pain is essential for diagnosis. Location: superficial entry pain (at vaginal introitus or along shaft of penis) vs deep pain (with deep thrusting, in lower abdomen or pelvis). Timing: pain only during penetration, during the entire act, or persisting for hours after intercourse (post-coital pain — common in endometriosis). Associated features: vaginal dryness, burning, or itching (vulvovaginal atrophy, vulvodynia, infection); visible skin changes on the vulva or penis (lichen sclerosus, dermatitis, herpes); difficulty with or inability to achieve penetration (vaginismus — involuntary muscle spasm); pain with tampon insertion or gynaecological examination (provoked vestibulodynia); cyclical pain worsening at menstruation (endometriosis); urinary symptoms (interstitial cystitis); penile curvature or nodules (Peyronie's disease). Vaginismus spectrum: now classified as genitopelvic pain/penetration disorder (GPPPD) in DSM-5 — involving anticipatory fear, hypertonicity of the pelvic floor, and avoidance of penetration — often coexisting with provoked vestibulodynia.

A thorough clinical history is the cornerstone: onset (lifelong vs acquired), relationship to the sexual cycle, triggers, associated symptoms, menstrual history, contraceptive use, hormonal status (menopausal symptoms), sexual history, history of infections or STIs, past gynaecological procedures, and psychosocial factors. Examination: external genital inspection (skin changes, atrophy, fissures, lichen sclerosus — white atrophic plaques); Q-tip test for vestibulodynia (cotton swab applied at clock positions around the vestibule — mapping allodynia); speculum examination (discharge, cervical pathology); bimanual examination (uterine size, mobility, adnexal masses, posterior fornix tenderness — endometriosis). In men: examination of the foreskin, glans, penile shaft, testes, and prostate. Investigations: vulval/vaginal swabs (microscopy, culture, STI screen — gonorrhoea/chlamydia NAAT), vaginal pH (atrophy — pH above 5); pelvic ultrasound (ovarian cysts, fibroids, endometriomas); diagnostic laparoscopy (definitive diagnosis of endometriosis, pelvic adhesions); urine cytology and cystoscopy (interstitial cystitis — if urinary symptoms prominent). Biopsy: for suspicious vulval or penile lesions (to exclude malignancy). Psychosexual assessment: validated tools (Female Sexual Function Index, FSFI; Sexual Distress Scale) help quantify impact.

Vulvovaginal atrophy (GSM): topical vaginal oestrogen (cream, ring, pessary) — restores mucosa, reduces dryness and friction; safe long-term including in women on systemic HRT; ospemifene (oral SERM) is an alternative; vaginal moisturisers (Replens, YES WB) and lubricants (water-based or silicone-based — not oil-based with latex condoms) provide immediate symptomatic relief. Provoked vestibulodynia / vulvodynia: pelvic floor physiotherapy (first-line — reduces hypertonicity, desensitises the vestibule through graduated tactile exposure); topical lidocaine gel (5% — applied before intercourse or examination); topical amitriptyline/baclofen compounded cream; oral amitriptyline (10-75 mg nocte), gabapentin, or pregabalin for neuropathic pain; vestibulectomy (surgical excision of the sensitive vestibular tissue) — effective in provoked vestibulodynia when conservative measures fail, with 70-90% improvement. Vaginismus/GPPPD: pelvic floor physiotherapy and progressive vaginal dilator therapy; CBT and psychosexual therapy; vaginal botulinum toxin (BTX) injections to the bulbospongiosus and levator ani — effective for refractory vaginismus. Endometriosis: medical suppression and/or laparoscopic excision. Infections: pathogen-specific antimicrobials. Lichen sclerosus: potent topical corticosteroids (clobetasol propionate 0.05%). Peyronie's disease: collagenase clostridium histolyticum (CCH) injections; surgery for stable Peyronie's causing severe deformity. Psychosexual therapy: CBT addressing pain catastrophisation, sexual anxiety, avoidance, and relationship communication — improves all forms of dyspareunia regardless of physical cause.

Untreated dyspareunia and its underlying causes lead to significant personal, relational, psychological, and physical complications. Psychological complications: conditioned pain responses develop when dyspareunia persists — anticipatory anxiety about pain causes avoidance of intercourse, which in turn reduces arousal and natural lubrication, worsening friction and pain and creating a progressive vicious cycle; depression and anxiety are highly prevalent in women with chronic dyspareunia; vulvodynia and provoked vestibulodynia cause significant distress and reduced quality of life, often taking years to receive a correct diagnosis. Relationship impact: sexual avoidance causes relationship strain, emotional distance, feelings of rejection in partners, and relationship breakdown; communication difficulties around sexual pain worsen all outcomes and require proactive couples counselling. Progression of underlying conditions: untreated endometriosis causes progressive pelvic adhesions, bowel and bladder involvement (rectovaginal endometriosis causing diarrhoea, rectal bleeding; vesical endometriosis causing haematuria), and ultimately infertility — dyspareunia is an early symptom that must not be dismissed. Lichen sclerosus: untreated causes progressive vulval scarring (labial fusion, buried clitoris, phimosis in men), fissuring, and approximately 5% lifetime risk of vulval squamous cell carcinoma — requiring regular surveillance. Peyronie's disease: progressive penile curvature causes inability to achieve penetration and erectile dysfunction, with depression in the majority of affected men. Vaginismus/GPPPD: untreated leads to complete penetration avoidance and infertility (inability to have unassisted intercourse for natural conception). Diagnostic delays are common — on average, women with vulvodynia wait 5–7 years for diagnosis, during which progressive psychological and relational harm accumulates.

Adequate lubrication: use vaginal lubricants during intercourse — silicone-based lubricants last longer and are safe with most condoms (except silicone sex toys); water-based lubricants are compatible with all materials. Avoid harsh soaps, bubble baths, and scented products on the vulva or penis — these disrupt the mucosal barrier and can cause or worsen contact dermatitis and vulvodynia. Treat menopausal vaginal changes proactively: start vaginal oestrogen as symptoms emerge — do not wait for severe atrophy. Treat infections promptly. Pelvic floor awareness: voluntary pelvic floor relaxation exercises (in addition to strengthening — Kegels are not appropriate if the pelvic floor is already hypertonic, as in vaginismus). Open communication with a partner about pain — 'spectatoring' (self-monitoring during sex) increases anxiety and worsens dyspareunia. Seeking early specialist review prevents the progression of conditioned pain responses and anticipatory anxiety which can make dyspareunia increasingly difficult to treat.

See your GP or gynaecologist for any pain during intercourse that persists beyond a single episode — dyspareunia is always a symptom worthy of medical assessment and is not 'normal'. Seek prompt assessment for: new vulval or penile skin changes (white patches, ulcers, raised lesions — to exclude malignancy), vaginal discharge with an odour or itch (infection), post-coital bleeding in women (requires cervical and endometrial assessment), or new deep pelvic pain during intercourse (possible endometriosis or pelvic pathology). Seek urgent same-day assessment for severe vulval or scrotal pain with swelling, erythema, or fever (possible abscess, necrotising fasciitis, or Fournier's gangrene — surgical emergency). Many people delay seeking help due to embarrassment — healthcare professionals assess dyspareunia regularly and without judgment. Early treatment leads to better outcomes and prevents the development of secondary psychological and relationship impacts from chronic sexual pain.